PortfoliosLab logo
QNCX vs. DAL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between QNCX and DAL is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

QNCX vs. DAL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cortexyme Inc (QNCX) and Delta Air Lines, Inc. (DAL). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%December2025FebruaryMarchAprilMay
-96.72%
-23.77%
QNCX
DAL

Key characteristics

Sharpe Ratio

QNCX:

0.03

DAL:

-0.36

Sortino Ratio

QNCX:

0.79

DAL:

-0.27

Omega Ratio

QNCX:

1.09

DAL:

0.97

Calmar Ratio

QNCX:

0.02

DAL:

-0.35

Martin Ratio

QNCX:

0.08

DAL:

-0.93

Ulcer Index

QNCX:

29.64%

DAL:

18.15%

Daily Std Dev

QNCX:

89.33%

DAL:

46.72%

Max Drawdown

QNCX:

-99.55%

DAL:

-81.73%

Current Drawdown

QNCX:

-99.10%

DAL:

-39.76%

Fundamentals

Market Cap

QNCX:

$48.54M

DAL:

$27.48B

EPS

QNCX:

-$1.31

DAL:

$5.64

PS Ratio

QNCX:

0.00

DAL:

0.45

PB Ratio

QNCX:

1.61

DAL:

1.76

Total Revenue (TTM)

QNCX:

$168.00K

DAL:

$61.93B

Gross Profit (TTM)

QNCX:

$40.00K

DAL:

$14.95B

EBITDA (TTM)

QNCX:

-$27.35M

DAL:

$7.47B

Returns By Period

In the year-to-date period, QNCX achieves a -42.25% return, which is significantly lower than DAL's -31.24% return.


QNCX

YTD

-42.25%

1M

-14.96%

6M

-33.33%

1Y

8.72%

5Y*

-52.57%

10Y*

N/A

DAL

YTD

-31.24%

1M

-2.17%

6M

-27.30%

1Y

-16.14%

5Y*

11.91%

10Y*

0.34%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

QNCX vs. DAL — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QNCX
The Risk-Adjusted Performance Rank of QNCX is 5555
Overall Rank
The Sharpe Ratio Rank of QNCX is 5252
Sharpe Ratio Rank
The Sortino Ratio Rank of QNCX is 6060
Sortino Ratio Rank
The Omega Ratio Rank of QNCX is 5757
Omega Ratio Rank
The Calmar Ratio Rank of QNCX is 5353
Calmar Ratio Rank
The Martin Ratio Rank of QNCX is 5252
Martin Ratio Rank

DAL
The Risk-Adjusted Performance Rank of DAL is 3030
Overall Rank
The Sharpe Ratio Rank of DAL is 3232
Sharpe Ratio Rank
The Sortino Ratio Rank of DAL is 2929
Sortino Ratio Rank
The Omega Ratio Rank of DAL is 3030
Omega Ratio Rank
The Calmar Ratio Rank of DAL is 2929
Calmar Ratio Rank
The Martin Ratio Rank of DAL is 3131
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

QNCX vs. DAL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cortexyme Inc (QNCX) and Delta Air Lines, Inc. (DAL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for QNCX, currently valued at 0.03, compared to the broader market-2.00-1.000.001.002.003.00
QNCX: 0.03
DAL: -0.36
The chart of Sortino ratio for QNCX, currently valued at 0.79, compared to the broader market-6.00-4.00-2.000.002.004.00
QNCX: 0.79
DAL: -0.27
The chart of Omega ratio for QNCX, currently valued at 1.09, compared to the broader market0.501.001.502.00
QNCX: 1.09
DAL: 0.97
The chart of Calmar ratio for QNCX, currently valued at 0.02, compared to the broader market0.001.002.003.004.005.00
QNCX: 0.02
DAL: -0.35
The chart of Martin ratio for QNCX, currently valued at 0.08, compared to the broader market-10.000.0010.0020.00
QNCX: 0.08
DAL: -0.93

The current QNCX Sharpe Ratio is 0.03, which is higher than the DAL Sharpe Ratio of -0.36. The chart below compares the historical Sharpe Ratios of QNCX and DAL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
0.03
-0.36
QNCX
DAL

Dividends

QNCX vs. DAL - Dividend Comparison

QNCX has not paid dividends to shareholders, while DAL's dividend yield for the trailing twelve months is around 1.33%.


TTM20242023202220212020201920182017201620152014
QNCX
Cortexyme Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DAL
Delta Air Lines, Inc.
1.33%0.83%0.50%0.00%0.00%1.00%2.58%2.63%1.81%1.37%0.89%0.61%

Drawdowns

QNCX vs. DAL - Drawdown Comparison

The maximum QNCX drawdown since its inception was -99.55%, which is greater than DAL's maximum drawdown of -81.73%. Use the drawdown chart below to compare losses from any high point for QNCX and DAL. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-99.10%
-39.76%
QNCX
DAL

Volatility

QNCX vs. DAL - Volatility Comparison

The current volatility for Cortexyme Inc (QNCX) is 21.17%, while Delta Air Lines, Inc. (DAL) has a volatility of 28.82%. This indicates that QNCX experiences smaller price fluctuations and is considered to be less risky than DAL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%December2025FebruaryMarchAprilMay
21.17%
28.82%
QNCX
DAL

Financials

QNCX vs. DAL - Financials Comparison

This section allows you to compare key financial metrics between Cortexyme Inc and Delta Air Lines, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20212022202320242025
168.00K
14.04B
(QNCX) Total Revenue
(DAL) Total Revenue
Values in USD except per share items